Speaker illustration

Doctor Skanda Rajasundaram

University of Oxford and Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Tumour necrosis factor receptor 1 inhibition and cardiovascular disease: a cis-Mendelian randomization study

Event: ESC Preventive Cardiology 2023

Topic: Cardiovascular Epidemiology

Session: Young Investigators Award - Population Science and Public Health


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb